CompletedNCT04991649
ACT for Parents of Children With Neurodevelopmental Comorbidities
Behavioural studyAges 3–12ChinaADHD
Understand this study
Who was this study for?
Listed age limits: 3 years to 12 years.
- Listed locations
- TuenmenSee all locations and recruitment
Study information
Study start dateStarted: April 11, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 118
- Sponsor
- Chinese University of Hong Kong
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 3 Years to 12 Years
- Official registry ID
- NCT04991649
- Official title
Show the full official title
Effects of Acceptance and Commitment Therapy-based Asthma Management Training Program for Parents of Young Children With Neurodevelopmental Comorbidities: A Randomized Controlled Trial
Recruitment & locations
CompletedTuenmen, Hong Kong · China
Questions about this study
Who is behind this study?
The study sponsor is Chinese University of Hong Kong, a university.
Who was this study for?
Listed age limits: 3 years to 12 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder
A Randomized Controlled Study of MEFP for Preschool Children With ADHD